SFT Stock Overview
Operates as a trading company in the pharmaceutical sector in Bulgaria and Serbia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Sopharma Trading AD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | лв5.85 |
| 52 Week High | лв6.75 |
| 52 Week Low | лв5.50 |
| Beta | 0.016 |
| 1 Month Change | 1.74% |
| 3 Month Change | 0.86% |
| 1 Year Change | -4.88% |
| 3 Year Change | 11.43% |
| 5 Year Change | -17.61% |
| Change since IPO | 26.90% |
Recent News & Updates
Recent updates
We're Not Counting On Sopharma Trading AD (BUL:SO5) To Sustain Its Statutory Profitability
Feb 14
If You Had Bought Sopharma Trading AD's (BUL:SO5) Shares Three Years Ago You Would Be Down 27%
Dec 18We Wouldn't Rely On Sopharma Trading AD's (BUL:SO5) Statutory Earnings As A Guide
Aug 10
Sopharma Trading AD's (BUL:SO5) Shareholders Are Down 35% On Their Shares
Jul 20Shareholder Returns
| SFT | BG Healthcare | BG Market | |
|---|---|---|---|
| 7D | -0.8% | 0.5% | -0.1% |
| 1Y | -4.9% | 1.6% | 17.9% |
Return vs Industry: SFT underperformed the BG Healthcare industry which returned 1.6% over the past year.
Return vs Market: SFT underperformed the BG Market which returned 17.9% over the past year.
Price Volatility
| SFT volatility | |
|---|---|
| SFT Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in BG Market | 8.3% |
| 10% least volatile stocks in BG Market | 1.9% |
Stable Share Price: SFT has not had significant price volatility in the past 3 months.
Volatility Over Time: SFT's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,616 | Ventsislav Marinov | www.sopharmatrading.bg |
Sopharma Trading AD operates as a trading company in the pharmaceutical sector in Bulgaria and Serbia. It offers its customers various pharmaceutical products, including a portfolio of various brands, medicines, medical devices, consumables, food supplements, cosmetics, and medical equipment. The company also provides logistic solutions for the import, storage, and distribution of pharmaceutical products, as well as marketing and advertising services.
Sopharma Trading AD Fundamentals Summary
| SFT fundamental statistics | |
|---|---|
| Market cap | лв200.51m |
| Earnings (TTM) | лв32.36m |
| Revenue (TTM) | лв1.73b |
6.2x
P/E Ratio0.1x
P/S RatioIs SFT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SFT income statement (TTM) | |
|---|---|
| Revenue | лв1.73b |
| Cost of Revenue | лв1.52b |
| Gross Profit | лв204.36m |
| Other Expenses | лв172.00m |
| Earnings | лв32.36m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.94 |
| Gross Margin | 11.82% |
| Net Profit Margin | 1.87% |
| Debt/Equity Ratio | 145.6% |
How did SFT perform over the long term?
See historical performance and comparison